NeurosciencebioRxivPreprint
Vutiglabridin improves neurodegeneration in MPTP-induced Parkinson's disease mice by targeting mitochondrial paraoxonase-2
Sora Kang, Leo Sungwong Choi, Suyeol Im…·Youngmi Kim Pak
Vutiglabridin, a clinical-stage drug for obesity, shows neuroprotective effects in Parkinson's disease models by targeting mitochondrial PON2.
1 citation